Real life experience with omalizumab in patients with poorly controlled moderate to severe asthma

被引：0
|
作者：
Ricciardi, L. [1 ]
Arena, E. [1 ]
Loschiavo, G. [1 ]
D'Angelo, A. G. [1 ]
Sinagra, F. [1 ]
Paffumi, I [1 ]
Saitta, S. [1 ]
Marotta, G. [1 ]
机构：
[1] Univ Hosp, Allergy & Clin Immunol Unit, Messina, Italy
来源：
ALLERGY | 2013年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：375 / 375
页数：1
相关论文
共 50 条
  • [41] Omalizumab Improves Asthma Symptoms, Asthma Control, and Health-Related Quality of Life in Chinese Patients With Moderate-to-Severe Asthma
    Li, Jing
    Kang, Jian
    Wang, Changzheng
    Yang, Jing
    Humphries, Michael
    Greenberg, Steven
    Zhong, Nanshan
    CHEST, 2016, 149 (04) : 6A - 6A
  • [42] Improvement in quality of life with omalizumab in patients with severe allergic asthma
    Chipps, Bradley
    Buhl, Roland
    Beeh, Kai-Michael
    Fox, Howard
    Thomas, Karen
    Reisner, Colin
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (11) : 2201 - 2208
  • [43] Seven years of clinical experience with omalizumab for moderate-severe allergic asthma treatment
    Morales-Cabeza, C.
    Buendia-Bravo, S.
    Baeza, M. L.
    Rodriguez-Gonzalez, C. G.
    Sanjurjo-Saez, M.
    Zubeldia, J. M.
    ALLERGY, 2016, 71 : 257 - 257
  • [44] REAL LIFE EXPERIENCE WITH BENRALIZUMAB IN PATIENTS WITH SEVERE UNCONTROLLED EOSINOPHILIC ASTHMA
    Murphy, E.
    Diaz, J.
    Singh, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S36 - S37
  • [45] Omalizumab Therapy For Moderate To Severe Asthma In Private Allergy Practice: a Six Year Experience
    Randolph, C. C.
    Kearney, D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB199 - AB199
  • [46] The real world effect of omalizumab add on therapy for patients with moderate to severe allergic asthma: The ASTERIX Observational study
    Bhutani, Mohit
    Yang, William H.
    Hebert, Jacques
    de Takacsy, Frederica
    Stril, Jean-Louis
    PLOS ONE, 2017, 12 (08):
  • [47] OMALIZUMAB IMPROVES QUALITY OF LIFE AND ASTHMA CONTROL IN CHINESE PATIENTS WITH MODERATE-TO-SEVERE ASTHMA: A RANDOMIZED PHASE III STUDY
    Li, J.
    Kang, J.
    Canvin, J.
    Wang, C.
    Zhong Nanshan
    Yang, J.
    Humphries, M.
    RESPIROLOGY, 2014, 19 : 2 - 2
  • [48] Real life experience with omalizumab and mepolizumab in severe asthma : do patient baseline features preclude effectiveness comparison ?
    Frix, An
    Schleich, Florence
    Paulus, Virginie
    Henket, Monique
    Guissard, Francoise
    Louis, Renaud
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [49] Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab
    Long, Aidan
    Rahmaoui, Abdelkader
    Rothman, Kenneth J.
    Guinan, Eva
    Eisner, Mark
    Bradley, Mary S.
    Iribarren, Carlos
    Chen, Hubert
    Carrigan, Gillis
    Rosen, Karin
    Szefler, Stanley J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 134 (03) : 560 - +
  • [50] Clinical Response Predictive Model for Omalizumab in Moderate-to-Severe Asthma Patients
    Qian, Ruiqi
    Yang, Lingyi
    Shen, Xurui
    Chen, Cheng
    Huang, Jianan
    Zhang, Xiuqin
    Fu, Cuiping
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2024, 2024
12345